Creating Extraordinary Value in Treating Cancer and Systemic Infections

by Transforming Hyperthermal Therapy into Precision Immuno-Oncology

PyRxia^™ is building a closed-loop, biomarker-guided immuno-thermal platform for patients with refractory metastatic cancer who have exhausted standard treatment options. This same platform offers additional opportunities to effectively treat systemic infections such as Lyme Disease.